O-003Gemcitabine with nab-paclitaxel in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): A quality of life randomized cross-over study (QOLINPAC). (20th June 2018) - Chiritescu, G; Dumon, K; Verslype, C; Prenen, H; Houbiers, G; Peeters, M; Janssens, J; Van Daele, D; Laurent, S; Arts, J; Hendrickx, K; Borbath, I; et al.